Placement Announced
Arovella Therapeutics placement
A$15m raised
Announced 26 Feb 2025 · ASX: ALA
Advisers
Arovella Therapeutics
Issuer
Not disclosed
Lead managers
- Joint lead manager
- Issuer
- Arovella Therapeutics
- Sector
- Biotech and pharmaceuticals
Similar deals
- Recce Pharmaceuticals entitlement offer Jun 2025 · A$15.8m · Biotech and pharmaceuticals
- Nyrada placement Sep 2026 · A$14m · Biotech and pharmaceuticals
- Paradigm Biopharmaceuticals placement Apr 2026 · A$14m · Biotech and pharmaceuticals
- Actinogen Medical placement Feb 2026 · A$17m · Biotech and pharmaceuticals
- Radiopharm Theranostics placement Jul 2026 · A$12.5m · Biotech and pharmaceuticals
Sources
- 26 Feb 2025 Arovella $15m Placement to fund Phase 1 ASX